Nav: Home

Chloride-channel in muscle cells provides new insights for muscle diseases

April 30, 2019

Small molecules such as hormones and ions are constantly transported in and out from our cells. This regulates what the cells do in our bodies. That is also why many researchers try to understand what controls the different channels in our cells. They have now greatly improved this understanding for muscle cells.

In a new study, an international and inter-disciplinary team involving researchers from the Faculty of Science and the Faculty of Health and Medical Sciences at the University of Copenhagen have mapped the structure of a channel that transports chloride into our muscle cells. Detailed structures of the chloride channel will provide vital information in the quest to fully understand its regulation and thereby optimize development of better treatments of important diseases such as ALS, SMA or Myasthenia gravis.

"This channel in the muscle cells may be essential for the group of illnesses we call neuromuscular diseases. That applies, for instance, to ALS, which many people might know from the late physicist Stephen Hawking. Others have discovered that blocking the channel can alleviate the symptoms of ALS. Our new findings will spark on-going development efforts to block the channel," says Pontus Gourdon, Associate Professor at Department of Biomedical Sciences.

Cryo-electron microscopy

The researchers have investigated proteins that exist in the cell membranes of human cells using a state-of-the-art so-called cryo-electron microscope. It uses rays of electrons to visualise the 3D-structures of different biological molecules.

In this instance, the researchers have taken what one might call a 3D-photography of this chloride-channel in muscle cells. Visualisations like these pave the way to more efficient drug development because they allow a more rational effort on medical compounds that can bind to that specific 3D-structure.

NMD Pharma

Previous work from Aarhus University has revealed that the chloride-channel is critical for maintenance of skeletal muscle function during physical activity, and this led to the formation of NMD Pharma, a pharmaceutical company that is pursuing new treatments for neuromuscular disorders by targeting the chloride channel.

The researchers have now initiated a collaboration with NMD Pharma that will use the new knowledge for drug development. A postdoc from the research group at the university will collaborate closely with scientists of NMD Pharma to help make the most of the new findings.

Value in society

The new post-doc employment is part of the public-private partnership called BRIDGE between university and industry. The goal is to make sure that knowledge from research results makes it beyond scientific publications and has a positive impact in society. The program is supported by the Novo Nordisk Foundation.

"We are extremely proud of the fact that our research might lead to real impact in society through this collaboration. And also of the fact that the industry can see the values of our findings," says Pontus Gourdon.

He emphasizes that drug development can take a long time and that approval of new drugs is no quick process either.

The new results are especially relevant for neuromuscular diseases such as Thomsen's disease.

It is a heritable disease named after the Danish physician Asmus Julius Thomas Thomsen who described the disease in 1876. Many in his family, including himself, suffered from the disease.
-end-
The study is funded by The Lundbeck Foundation, Knut and Alice Wallenbergs Foundation, The Carlsberg Foundation and the Novo Nordisk Foundation.

The new study is published in the scientific journal PLOS Biology. Read the scientific article: "Structure of the human ClC-1 chloride channel".

University of Copenhagen The Faculty of Health and Medical Sciences

Related Drug Development Articles:

Novel paradigm in drug development
Targeted protein degradation (TPD) is a new paradigm in drug discovery that could lead to the development of new medicines to treat diseases such as cancer more effectively.
Turbo chip for drug development
In spite of increasing demand, the number of newly developed drugs decreased continuously in the past decades.
A breakthrough for brain tumor drug development
Glioblastoma is a devastating disease with poor survival stats due in part to a lack of preclinical models for new drug testing.
Researchers diversify drug development options with new metal catalyst
A University of Illinois team of researchers led by chemistry professor M.
DNA with a twist: Discovery could further antibiotic drug development
Scientists reveal how a 'molecular machine' in bacterial cells prevents fatal DNA twisting, which could be crucial in the development of new antibiotic treatments.
Drug development stakeholders call for improved pharmaceutical testing
Published in Drug Discovery Today, 'Advancing Nonclinical Innovation and Safety in Pharmaceutical Testing' identifies the necessary steps that will lead to safer and more effective medicines, guided by a greater focus on human-based in vitro and in silico methods, which allow scientists to observe human cells, tissues, and biological processes, and their interaction with potential medications.
A new way to create molecules for drug development
Chemists at The Ohio State University have developed a new and improved way to generate molecules that can enable the design of new types of synthetic drugs.
New insight into Huntington's disease may open door to drug development
McMaster University researchers have developed a new theory on Huntington's disease which is being welcomed for showing promise to open new avenues of drug development for the condition.
Schizophrenia drug development may be 'de-risked' with new research tool
Researchers have identified biomarkers that can help with development of better treatments for schizophrenia.
Researchers map trends in drug development
One third of all drugs on the American market act on the same kind of important cell receptor -- the G protein-coupled receptors.
More Drug Development News and Drug Development Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab